1xw7: Difference between revisions
New page: left|200px<br /> <applet load="1xw7" size="450" color="white" frame="true" align="right" spinBox="true" caption="1xw7, resolution 2.30Å" /> '''Diabetes-Associated... |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:1xw7.gif|left|200px]]<br /> | [[Image:1xw7.gif|left|200px]]<br /><applet load="1xw7" size="350" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="1xw7" size=" | |||
caption="1xw7, resolution 2.30Å" /> | caption="1xw7, resolution 2.30Å" /> | ||
'''Diabetes-Associated Mutations in Human Insulin: Crystal Structure and Photo-Cross-Linking Studies of A-Chain Variant Insulin Wakayama'''<br /> | '''Diabetes-Associated Mutations in Human Insulin: Crystal Structure and Photo-Cross-Linking Studies of A-Chain Variant Insulin Wakayama'''<br /> | ||
==Overview== | ==Overview== | ||
Naturally occurring mutations in insulin associated with diabetes mellitus | Naturally occurring mutations in insulin associated with diabetes mellitus identify critical determinants of its biological activity. Here, we describe the crystal structure of insulin Wakayama, a clinical variant in which a conserved valine in the A chain (residue A3) is substituted by leucine. The substitution occurs within a crevice adjoining the classical receptor-binding surface and impairs receptor binding by 500-fold, an unusually severe decrement among mutant insulins. To resolve whether such decreased activity is directly or indirectly mediated by the variant side chain, we have determined the crystal structure of Leu(A3)-insulin and investigated the photo-cross-linking properties of an A3 analogue containing p-azidophenylalanine. The structure, characterized in a novel crystal form as an R(6) zinc hexamer at 2.3 A resolution, is essentially identical to that of the wild-type R(6) hexamer. The variant side chain remains buried in a nativelike crevice with small adjustments in surrounding side chains. The corresponding photoactivatable analogue, although of low affinity, exhibits efficient cross-linking to the insulin receptor. The site of photo-cross-linking lies within a 14 kDa C-terminal domain of the alpha-subunit. This domain, unrelated in sequence to the major insulin-binding region in the N-terminal L1 beta-helix, is also contacted by photoactivatable probes at positions A8 and B25. Packing of Val(A3) at this interface may require a conformational change in the B chain to expose the A3-related crevice. The structure of insulin Wakayama thus evokes the reasoning of Sherlock Holmes in "the curious incident of the dog in the night": the apparent absence of structural perturbations (like the dog that did not bark) provides a critical clue to the function of a hidden receptor-binding surface. | ||
==Disease== | ==Disease== | ||
Line 11: | Line 10: | ||
==About this Structure== | ==About this Structure== | ||
1XW7 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/ ] with ZN, CL and IPH as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http:// | 1XW7 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/ ] with <scene name='pdbligand=ZN:'>ZN</scene>, <scene name='pdbligand=CL:'>CL</scene> and <scene name='pdbligand=IPH:'>IPH</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1XW7 OCA]. | ||
==Reference== | ==Reference== | ||
Diabetes-associated mutations in human insulin: crystal structure and photo-cross-linking studies of a-chain variant insulin Wakayama., Wan ZL, Huang K, Xu B, Hu SQ, Wang S, Chu YC, Katsoyannis PG, Weiss MA, Biochemistry. 2005 Apr 5;44(13):5000-16. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=15794638 15794638] | Diabetes-associated mutations in human insulin: crystal structure and photo-cross-linking studies of a-chain variant insulin Wakayama., Wan ZL, Huang K, Xu B, Hu SQ, Wang S, Chu YC, Katsoyannis PG, Weiss MA, Biochemistry. 2005 Apr 5;44(13):5000-16. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=15794638 15794638] | ||
[[Category: Protein complex]] | [[Category: Protein complex]] | ||
[[Category: Chu, Y | [[Category: Chu, Y C.]] | ||
[[Category: Hu, S | [[Category: Hu, S Q.]] | ||
[[Category: Huang, K.]] | [[Category: Huang, K.]] | ||
[[Category: Katsoyannis, P | [[Category: Katsoyannis, P G.]] | ||
[[Category: Wan, Z | [[Category: Wan, Z L.]] | ||
[[Category: Weiss, M | [[Category: Weiss, M A.]] | ||
[[Category: Xu, B.]] | [[Category: Xu, B.]] | ||
[[Category: CL]] | [[Category: CL]] | ||
Line 30: | Line 29: | ||
[[Category: protein unfolding]] | [[Category: protein unfolding]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:59:15 2008'' |